News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
Eric Richman has been elected to Chairman of the Board at LabConnect, LLC, a global provider of central laboratory and support services. He succeeds Alain Chetrit, LabConnect cofounder and chairman, who will now serve as Chairman emeritus.
Richman was a member of the founding team at MedImmune and from 2007 through 2015 was president and CEO of PharmAthene, Inc.
He had been a director of LabConnect since 2017 and also serves on the Boards of ADMA Biologics and NovelStem, Inc.
“In this era of highly complex lab testing, one of my key objectives is to be recognized as the go-to service provider for specialized laboratory testing, kit building, sample management, data management and biorepository services,” Richman told us.